Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MiRNA based tumor mutation burden diagnostic and prognostic prediction models for endometrial cancer.

Bioengineered - 1 Dec 2021

Lu Nan, Liu Jinhui, Ji Chengjian, Wang Yichun, Wu Zhipeng, Yuan Shuning, Xing Yan, Diao Feiyang

Abstract excerpt

Uterus Corpus Endometrial cancer (UCEC) is the sixth most common malignant tumor worldwide. In this research, we identified diagnostic and prognostic biomarkers to reflect patients' immune microenvironment and prognostic. Various data of UCEC patients from the TCGA database were obtained. Firstly, patients were divided into a high tumor mutation burden (TMB) level group and a low TMB level group according to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Computational Biology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Databases, Genetic

Share to Endometrial Neoplasms

Share to Immunotherapy

Share to MicroRNAs

Share to Prognosis

Share to Transcriptome

Source

Open in PubMed Open full text

Identifiers

PMID: 34252354
DOI: 10.1080/21655979.2021.1947940
PMCID: PMC8806700

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MiRNA based tumor mutation burden diagnostic and prognostic prediction models for endometrial cancer.PMID 34252354Read ↗

An miRNA signature associated with tumor mutation burden in endometrial cancer.Semantic proximity Read ↗

Biological Omics Analysis of Tumor Mutation Burden Combined with Immune Infiltrates in Uterine Corpus Endometrial CarcinomaSemantic proximity Read ↗

Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinomaSemantic proximity Read ↗

Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer.Semantic proximity Read ↗

Construction of the Novel Immune Risk Scoring System Related to CD8 + T Cells in Uterine Corpus Endometrial CarcinomaSemantic proximity Read ↗

Cuproptosis-Associated lncRNA Gene Signature Establishes New Prognostic Profile and Predicts Immunotherapy Response in Endometrial CarcinomaSemantic proximity Read ↗

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and ChemotherapySemantic proximity Read ↗

Exploration of prognostic genes related to T cell-mediated tumor killing in uterine corpus endometrial cancer based on transcriptome data and experimental verificationSemantic proximity Read ↗

Significance of TP53 Mutational Status-Associated Signature in the Progression and Prognosis of Endometrial CarcinomaSemantic proximity Read ↗

Analysis of tumor mutation burden combined with immune infiltrates in endometrial cancerSemantic proximity Read ↗

A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables.Semantic proximity Read ↗

Construction of a miRNA-Based Nomogram Model to Predict the Prognosis of Endometrial CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.